Fundraising FoxCaaMTech
2 known investors
Find your way into CaaMTech
Sign up to see every warm intro you have to CaaMTech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CaaMTech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CaaMTech is a pharmaceutical drug discovery company that engineers novel small-molecule psychedelic-inspired therapeutics for mental health treatment through structure-activity optimization and safety screening. The company conducts fundamental research on tryptamine compounds, develops intellectual property, and aims to support the psychedelics industry with scientific foundations and validated drug candidates.
Founders & leadership
Investors · 2
Frequently asked questions
- What does CaaMTech do?
- CaaMTech is a pharmaceutical drug discovery company that engineers novel small-molecule psychedelic-inspired therapeutics for mental health treatment through structure-activity optimization and safety screening. The company conducts fundamental research on tryptamine compounds, develops intellectual property, and aims to support the psychedelics industry with scientific foundations and validated drug candidates.
- Who founded CaaMTech?
- CaaMTech was founded by Andrew Chadeayne.
- Who are CaaMTech's investors?
- CaaMTech's investors include Kortschak Investments L.P., Noetic.